-
Radon action in municipal law
This document surveys the legal powers of municipalities to address radon. It is designed to be read along other documents that detail policy rationales for why provinces and... -
Regulatory Directive: The PMRA Initiative for Reduced-Risk Pesticides
The purpose of this regulatory directive is to inform applicants, provinces and territories, user groups, and other interested parties that the North American Free Trade... -
Canada-Nova Scotia Bilateral Agreement for Pan-Canadian Virtual Care...
Canada and Nova Scotia agree that immediate action and collaboration was and continues to be needed among governments to expand virtual care services to support improved access... -
Carbon black
Questions and answers regarding the uses of carbon black and actions taken to protect the public and the environment. -
Minister of Health pocket book 2025
Ministerial briefing pocketbook 2025 -
Radiation surveillance program
Radiation is a part of Canada's environment. We have several measurement programs in place to protect the health of Canadians by continually monitoring natural and man-made... -
WTO-member countries eligible to import under Canada's Access to Medicines Regime
It presents WTO-Member Countries Eligible to Import Under the Regime -
Proposed Re-evaluation Decision PRVD2020-10, Kresoxim-methyl and Its...
This document (PRVD2020-10, Kresoxim-methyl and Its Associated End-use Products) presents the proposed regulatory decision for the re-evaluation of kresoxim-methyl including the... -
Guidance for market authorization requirements for COVID-19 drugs: Labelling...
A product monograph is a factual, scientific document on a drug product. It does not contain promotional material. The monograph describes the properties, claims, indications... -
Registration Decision RD2022-06, Canola Oil, Goodnature Rat & Mouse Lure,...
This decision is consistent with the Proposed Registration Decision PRD2022-03, Canola Oil, Goodnature Rat & Mouse Lure, and Goodnature Rat & Mouse Pre-Feed Lure. -
Guidance Document: Nonprescription Oral Paediatric Cough and Cold Labelling Standard
This Labelling Standard describes the requirements necessary to receive marketing authorization (a Drug Identification Number (DIN)) for single and multiple-ingredient orally... -
Novel food information: Ahiflower Oil
Health Canada has notified Nature's Crops International that it has no objection to the sale of Ahiflower® oil as an ingredient for use in foods and beverages sold in Canada at... -
Keep children cool! Protect your child from extreme heat
Extreme heat, and heat related illnesses, are especially dangerous for infants and young children. -
Summary Safety Review - SGLT2 inhibitors - Assessing the potential risk of a...
After receiving two Canadian case reports involving canagliflozin, Health Canada reviewed the potential risk of PRES in patients treated with SGLT2 inhibitors who have developed... -
Notice - Prescription Drug List (PDL): Ibuprofen
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Ibuprofen to nonprescription status for... -
Special Committee on COVID
Briefing binder for the Minister of Health’s appearances at the Special Committee on the COVID-19 Pandemic (COVI) – Week of May 11, 2020 -
Clinical Trial Applications (CTAs) - requirements
The following section provides the requirements for a CTA involving the use of pharmaceutical, biological, and radiopharmaceutical drugs. The requirements are the same for these... -
Products susceptible to illegal marketing: Illegal marketing of opioids and...
Requirements for marketing opioid drugs, what to watch for, and how you can help. -
Mandatory Incident Reporting for Registrants and Applicants
In accordance with the Pest Control Products Incident Reporting Regulations, pesticide registrants and applicants are required to report to the Pest Management Regulatory Agency...
Vous pouvez également accéder à ce catalogue en utilisant l'API (cf. Documentation de l'API).